Correlation Between Broad Capital and Tekla Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Broad Capital and Tekla Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Broad Capital and Tekla Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Broad Capital Acquisition and Tekla Life Sciences, you can compare the effects of market volatilities on Broad Capital and Tekla Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Broad Capital with a short position of Tekla Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Broad Capital and Tekla Life.

Diversification Opportunities for Broad Capital and Tekla Life

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Broad and Tekla is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Broad Capital Acquisition and Tekla Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tekla Life Sciences and Broad Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Broad Capital Acquisition are associated (or correlated) with Tekla Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tekla Life Sciences has no effect on the direction of Broad Capital i.e., Broad Capital and Tekla Life go up and down completely randomly.

Pair Corralation between Broad Capital and Tekla Life

Assuming the 90 days horizon Broad Capital is expected to generate 2.27 times less return on investment than Tekla Life. In addition to that, Broad Capital is 1.1 times more volatile than Tekla Life Sciences. It trades about 0.02 of its total potential returns per unit of risk. Tekla Life Sciences is currently generating about 0.05 per unit of volatility. If you would invest  1,212  in Tekla Life Sciences on October 20, 2024 and sell it today you would earn a total of  136.00  from holding Tekla Life Sciences or generate 11.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Broad Capital Acquisition  vs.  Tekla Life Sciences

 Performance 
       Timeline  
Broad Capital Acquisition 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Broad Capital Acquisition are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable fundamental indicators, Broad Capital is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Tekla Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tekla Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest abnormal performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Broad Capital and Tekla Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Broad Capital and Tekla Life

The main advantage of trading using opposite Broad Capital and Tekla Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Broad Capital position performs unexpectedly, Tekla Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tekla Life will offset losses from the drop in Tekla Life's long position.
The idea behind Broad Capital Acquisition and Tekla Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk